Trump Just Stands There After Man Collapses During Press Conference
One of the guests at Donald Trump’s press conference on weight loss drugs passed out during the event.

A man who was reportedly taking weight loss medication appeared to collapse Thursday during a press conference to debut a deal to make those drugs more affordable, while President Donald Trump simply looked on.
Dr. Mehmet Oz, the daytime talk show host Trump picked to run the Centers for Medicare & Medicaid Services, rushed to help the man to the ground (Oz was a heart doctor before he became a pseudoscience-peddling daytime host). Meanwhile, Trump, who was sitting behind his desk while others ran the show, slowly stood up as he watched the man take to the floor.
As members of the press were quickly ushered out of the room, Trump turned away from the fallen man, staring off into space.
holy shit -- one of Trump's toadies just passed out and the White House event is brought to an abrupt end pic.twitter.com/o3nu5QUpcg
— Aaron Rupar (@atrupar) November 6, 2025
Multiple sources told The Washington Post’s Dan Diamond that the man was a patient who uses Elli Lily’s GLP-1 medication.
Press Secretary Karoline Leavitt said that the man was “okay” and being seen by the White House Medical Unit. Newsmax was quick to report that Trump—who was clearly not involved in the incident at all—was also okay.
Though, Trump didn’t exactly seem up-to-par while dully reading the announcement from his seat.
A senior administration official said that under Trump’s new deal with Novo Nordisk and Elli Lily, weight-loss drugs could have an out-of-pocket cost of between $50 to $350 per month, as opposed to the current list price of more than $1000. However, prices would likely not be significantly cheaper for those whose prescriptions are covered by insurance.
TrumpRx, the president’s scheme to transform the federal government into a pharmacy, is already raising red flags for legal and health experts. They warn that the marketing gimmick isn’t likely to help the average American, and could actually expose private information to a government that clearly doesn’t know how to handle it. Already, other drug companies such as Pfizer and EMD Serono, which produces fertility drugs, have made deals to sell discounted products through TrumpRx, in exchange for being spared from the president’s sweeping tariffs on pharmaceuticals.









